The Reporting of Harms in Randomized Controlled Trials of Hypertension Using the CONSORT Criteria for Harm Reporting

被引：22
|
作者：
Bagul, Nitin Babulal [1 ]
Kirkham, Jamie J. [2 ]
机构：
[1] Novartis Horsham Res Ctr, Horsham RH12 5AB, W Sussex, England
[2] Univ Liverpool, Dept Biostat, Liverpool L69 3GS, Merseyside, England
来源：
CLINICAL AND EXPERIMENTAL HYPERTENSION | 2012年 / 34卷 / 08期
关键词：
harm; adverse event; CONSORT; CONSORT extension; drug safety; ADVERSE EVENTS; QUALITY; STATEMENT; IMPROVE;
D O I：
10.3109/10641963.2012.681724
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The aim of this study was to assess the quality of reporting of harms in hypertension clinical trials identified from the Cochrane Database using the Consolidated Standards of Reporting Trials (CONSORT) extension for harms reporting. Forty-one hypertension trials were included in the study. On average trials reported less than half of the items recommended by the CONSORT extension for harms (mean 9.83 items; 95% confidence interval 8.06, 11.60). Trialists need to address the perceived shortcomings in measurement, analysis, and reporting of harms data so that the available trial data can be considered as a balanced and reliable source of evidence.
引用
收藏
页码：548 / 554
页数：7
相关论文
共 50 条
  • [41] Reporting of Complications in Retinal Detachment Surgical Trials A Systematic Review Using the CONSORT Extension for Harms
    Xu, Zheng Yang
    Azuara-Blanco, Augusto
    Kadonosono, Kazuaki
    Murray, Timothy
    Natarajan, Sundaram
    Sii, Samantha
    Smiddy, William
    Steel, David H.
    Wolfensberger, Thomas J.
    Lois, Noemi
    JAMA OPHTHALMOLOGY, 2021, 139 (08) : 898 - 905
  • [42] CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials
    Junqueira, Daniela R.
    Zorzela, Liliane
    Golder, Susan
    Loke, Yoon
    Gagnier, Joel J.
    Julious, Steven A.
    Li, Tianjing
    Mayo-Wilson, Evan
    Pham, Ba
    Phillips, Rachel
    Santaguida, Pasqualina
    Scherer, Roberta W.
    Gotzsche, Peter C.
    Moher, David
    Ioannidis, John P. A.
    Vohra, Sunita
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [43] Evaluation of reporting quality of randomized controlled trials in patients with COVID-19 using the CONSORT statement
    Yin, Yuhuan
    Shi, Fugui
    Zhang, Yiyin
    Zhang, Xiaoli
    Ye, Jianying
    Zhang, Juxia
    PLOS ONE, 2021, 16 (09):
  • [44] Reporting of randomized controlled trials in occupational therapy and speech therapy: Evaluation using an expansion of the CONSORT statement
    Norton-Mabus, Julie C.
    Nelson, David L.
    OTJR-OCCUPATION PARTICIPATION AND HEALTH, 2008, 28 (02) : 64 - 71
  • [45] THE QUALITY OF REPORTING IN RANDOMIZED CONTROLLED TRIALS OF HOME BASED REHABILITATION FOR KNEE OSTEOARTHRITIS: UTILIZING PEDRO SCORE AND CONSORT CRITERIA
    Meran, M.
    Unver, B.
    Caglar, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1329 - 1329
  • [46] Reporting quality of heart failure randomized controlled trials 2000-2020: Temporal trends in adherence to CONSORT criteria
    Jalloh, Mohamed B.
    Bot, Veronica A.
    Borjaille, Cristiana Z.
    Thabane, Lehana
    Li, Guowei
    Butler, Javed
    Zannad, Faiez
    Granger, Christopher B.
    Van Spall, Harriette G. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (06) : 1369 - 1380
  • [47] Completeness of Reporting in Randomized Controlled Trials of 3 Vaccines: A Review of Adherence to the CONSORT Checklist
    Scott, Pippa
    Ott, Franziska
    Egger, Matthias
    Low, Nicola
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (12) : 1286 - 1294
  • [48] The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist
    Devereaux, PJ
    Manns, BJ
    Ghali, WA
    Quan, H
    Guyatt, GH
    CONTROLLED CLINICAL TRIALS, 2002, 23 (04): : 380 - 388
  • [49] Erratum to: Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials
    Lehana Thabane
    Sally Hopewell
    Gillian A. Lancaster
    Christine M. Bond
    Claire L. Coleman
    Michael J. Campbell
    Sandra M. Eldridge
    Pilot and Feasibility Studies, 2 (1)
  • [50] Reporting Quality of Randomized Controlled Trials in Restless Legs Syndrome Based on the CONSORT Statement
    Rikos, Dimitrios
    Dardiotis, Efthimios
    Aloizou, Athina-Maria
    Siokas, Vasileios
    Zintzaras, Elias
    Hadjigeorgiou, Georgios M.
    TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2019, 9
12345